Commercial Pharmaceutical Supply – Sodium Chloride Injection (0.9%)

The contract is for the supply of sterile sodium chloride injection at 0.9% concentration, packaged in 1000mL latex-free IV bags that meet U.S. Pharmacopeia standards and are compliant with MMS No. 1 and MIL-STD-129 labeling requirements, all under FDA regulation. The product must be delivered within five days of contract award to ensure timely availability for medical use, with performance centered in Bogalusa, Louisiana, at zip code 70427-0000. The solicitation is structured as a subcontract under NAICS code 325412, which classifies it within the pharmaceutical and medicinal preparation manufacturing sector, and is managed by the Department of Defense through the Medical Supply Chain Pharm FSA. The opportunity was posted on July 28, 2026, with a response deadline of August 3, 2026, indicating a tight turnaround for prospective suppliers to submit proposals and demonstrate compliance with all regulatory, packaging, and delivery requirements.